Nebenwirkungen · Orfadin
Orfadin 2 mg hard capsules Orfadin 5 mg hard capsules Orfadin 10 mg hard capsules Orfadin 20 mg hard capsules · Abschnitt 4.8 · PDF-Seite 5–6
HOS-113121 · Präparat HOS-093849
5 MedDRA system organ Frequency in HT-1 Frequency in AKU1 Adverse reaction class Skin and subcutaneous Uncommon Exfoliative dermatitis, tissue disorders erythematous rash Uncommon Common Pruritus, rash Investigations Very common Very common Elevated tyrosine levels 1 The frequency is based on one clinical study in AKU. 2 Elevated tyrosine levels are associated with eye-related adverse reaction. Patients in the AKU study did not have a diet restricted in tyrosine and phenylalanine.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-04T13:48:00Z · SHA-256 d2301bd3b7146d81a83f0b30dfedb2d14565c57b83f31faec0b24a019fab3b2e · Passage a7ecaf69cccbfb5a2442ad11fa60fc181de5985ea09f707682f1687b5928e2b9 · Zeichen 2249–3016 im Abschnitt